Independent fund research. Built on SEC filings.

How we research funds

ETF · Large Blend · Rbb

F/m Emerald Special Situations ETF (SPIT)

Ticker SPIT · · Holdings as of Jul 31, 2026

Expense ratio
0.9%$90/yr per $10k
5-yr return
+16.0%annualized
1-yr return
+38.5%as of Dec 2025
Net assets
$33.4Mall share classes
Holdings
49

Bottom line

Is SPIT a good fund? The bottom line

SPIT is a managed large blend ETF from Rbb.

It charges 0.9% — about $90 a year on every $10,000 invested, more expensive than 56% of large blend funds we track.

It returned +38.5% over one year, +16.0% a year over five years, +17.5% a year over ten (as of Dec 31, 2025, per its prospectus).

With $33.4 million in net assets and 49 holdings, its largest position is Corcept Therapeutics Inc (5.4%) and the top 10 make up 34.6% of the portfolio.

What stands out

  • 5-year return beat 95% of category peers

What to watch

  • Small fund ($33.4 million) — small funds are likelier to close
  • High turnover (111% a year) can mean more taxable distributions

Updated Nov 19, 2026

What SPIT invests in

The investment objective of the F/m Emerald Special Situations ETF (the Fund) is to seek long-term growth through capital appreciation.

The Fund is an actively managed exchange-traded fund (ETF) and invests primarily in equity securities of companies experiencing unique, idiosyncratic situations and transformations (Special Situations), selected by Emerald Mutual Fund Advisers Trust (the Sub-Adviser), the Funds investment sub-adviser, under the supervision of the Adviser. The Sub-Advisers research staff conducts company-specific research analysis to identify securities of the companies in which an unusual and possibly non-repetitive development is taking place which, in the opinion of the Sub-Adviser, may cause the securities to attain a higher market value independently, to a degree, than the trend in the securities market in general. Under normal market conditions, the Fund invests at least 80% of its net assets (plus the amount of any borrowings for investment purposes) in equity securities issued by companies…

From the fund's prospectus (filed Sep 8, 2026).

SPIT performance

Fund calendar-year total returns, 2015–2025 2015: −4.1%; 2016: +3.8%; 2017: +22.9%; 2018: −8.8%; 2019: +36.7%; 2020: +50.1%; 2021: +23.7%; 2022: −30.9%; 2023: +41.2%; 2024: +25.6%; 2025: +38.5% −4% 2015 +4% 2016 +23% 2017 −9% 2018 +37% 2019 +50% 2020 +24% 2021 −31% 2022 +41% 2023 +26% 2024 +38% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
SPIT+38.5%+16.0%+17.5%
Large Blend median+13.8%+9.7%+10.9%

Source: Fund prospectus, as of Dec 31, 2025

Full SPIT performance history →

What SPIT costs

On a $10,000 investment, SPIT's 0.9% expense ratio costs about $90 a year. The prospectus estimates $1,108 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.

See the full SPIT fee table →

SPIT top 10 holdings

#Holding% of fund
1Corcept Therapeutics Inc CORT5.38%
2TETRA Technologies Inc TTI3.95%
3Amazon.com Inc AMZN3.89%
4Guardant Health Inc GH3.59%
5LivaNova PLC LIVN3.14%
6Excelerate Energy Inc EE3.09%
7Credo Technology Group Holding CRDO3.04%
8Arlo Technologies Inc ARLO3.04%
9Take-Two Interactive Software TTWO2.77%
10Skyward Specialty Insurance Gr SKWD2.72%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 34.6% of the fund. See all top 25 holdings and asset mix →

Alternatives to SPIT

More funds like SPIT →

SPIT FAQ

What is the expense ratio of SPIT?
SPIT's expense ratio is 0.9%, which works out to about $90 a year for every $10,000 invested. The prospectus estimates total costs of $1,108 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is SPIT a good investment?
It depends on your goals, but the data points to: 5-year return beat 95% of category peers; small fund ($33.4 million) — small funds are likelier to close; high turnover (111% a year) can mean more taxable distributions. This is general information, not personalized advice.
What does SPIT hold?
SPIT's largest holdings are Corcept Therapeutics Inc (5.4%), TETRA Technologies Inc (4.0%), Amazon.com Inc (3.9%), Guardant Health Inc (3.6%), LivaNova PLC (3.1%). It holds 49 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is SPIT's 5-year return?
SPIT returned +16.0% a year over the five years ending Dec 31, 2025, and +17.5% a year over ten years. Past performance does not guarantee future results.
Who manages SPIT?
SPIT is offered by Rbb through Rbb Fund, Inc..